Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant DiseasesCecilia Binda, Carlo Fabbri, Gabriele Capurso et al.|Microorganisms|2022Cited by 47
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Heiner Wedemeyer, Sabela Lens et al.|Clinical Gastroenterology and Hepatology|2025Cited by 17
WED-198 Incidence and clinical significance of recompensation after HCV- cureGeorg Semmler, Mattias Mandorfer, Sabela Lens et al.|Journal of Hepatology|2025Cited by 0